Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer

Oestrogen Receptor ◽

Term Outcome ◽

Long Term Outcome ◽

Oestrogen Receptor Status ◽

Receptor Status

Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6605360 ◽

2009 ◽

Vol 101 (9) ◽

pp. 1529-1536 ◽

Cited By ~ 51

Author(s):

T Hirata ◽

C Shimizu ◽

K Yonemori ◽

A Hirakawa ◽

T Kouno ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Primary Breast Cancer ◽

Hormone Receptor Status ◽

Term Outcome ◽

Long Term Outcome ◽

Receptor Status

Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status

European Journal of Cancer ◽

10.1016/j.ejca.2017.01.008 ◽

2017 ◽

Vol 75 ◽

pp. 323-332 ◽

Cited By ~ 10

Author(s):

Sylvie Giacchetti ◽

Anne-Sophie Hamy ◽

Suzette Delaloge ◽

Etienne Brain ◽

Frédérique Berger ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Her2 Status ◽

Breast Cancer Patients ◽

Term Outcome ◽

Abstract P3-08-15: Immunologic correlates of long-term outcome in the residual disease of triple-negative breast cancer after neoadjuvant chemotherapy

10.1158/1538-7445.sabcs19-p3-08-15 ◽

2020 ◽

Author(s):

Justin M Balko ◽

Mellissa Nixon ◽

Paula I Gonzalez-Ericsson ◽

Mark A Pilkinton ◽

Wyatt J McDonnell ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Residual Disease ◽

Term Outcome ◽

Abstract P5-06-12: Validation of residual proliferative cancer burden (RPCB) as a predictor of long-term outcome following neoadjuvant chemotherapy in hormone-receptor positive/HER2 negative breast cancer patients

10.1158/1538-7445.sabcs19-p5-06-12 ◽

2020 ◽

Author(s):

Federica Miglietta ◽

Vassilena Tsvetkova ◽

Maria Vittoria Dieci ◽

Gaia Griguolo ◽

Grazia Vernaci ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Breast Cancer Patients ◽

Term Outcome ◽

Long Term Outcome ◽

Cancer Burden ◽

Hormone Receptor Positive

A model for trial level prediction of long term outcome based on pathological complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.1031 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 1031-1031

Author(s):

Valentina Nekljudova ◽

Sibylle Loibl ◽

Gunter Von Minckwitz ◽

Stefan Gluck ◽

Richard Crane ◽

...

Keyword(s):

Breast Cancer ◽

Pathological Complete Response ◽

Early Stage ◽

Complete Response ◽

Early Stage Breast Cancer ◽

Term Outcome ◽

Validation of Residual Proliferative Cancer Burden as a Predictor of Long‐Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor‐Positive/Human Epidermal Growth Receptor 2‐Negative Breast Cancer

The Oncologist ◽

10.1634/theoncologist.2020-0201 ◽

2020 ◽

Vol 25 (9) ◽

Cited By ~ 1

Author(s):

Federica Miglietta ◽

Maria Vittoria Dieci ◽

Vassilena Tsvetkova ◽

Gaia Griguolo ◽

Grazia Vernaci ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Term Outcome ◽

Long Term Outcome ◽

Cancer Burden ◽

Hormone Receptor Positive ◽

Epidermal Growth

Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6602235 ◽

2004 ◽

Vol 91 (12) ◽

pp. 2012-2017 ◽

Cited By ~ 170

Author(s):

A E Ring ◽

I E Smith ◽

S Ashley ◽

L G Fulford ◽

S R Lakhani

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Oestrogen Receptor ◽

Pathological Complete Response ◽

Complete Response ◽

Oestrogen Receptor Status ◽

Receptor Status

Abstract PS13-08: Predictors and long-term outcome of pathologic complete response in patients receiving neoadjuvant chemotherapy for breast cancer - an NCDB analysis

10.1158/1538-7445.sabcs20-ps13-08 ◽

2021 ◽

Author(s):

Lauren Mikesell Panebianco ◽

Prashanth Ashok Kumar ◽

Shreya Sinha ◽

Dongliang Wang ◽

Danning Huang ◽

...

Keyword(s):

Breast Cancer ◽

Pathologic Complete Response ◽

Complete Response ◽

Term Outcome ◽

Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC)

Contemporary Clinical Trials ◽

10.1016/j.cct.2018.06.016 ◽

2018 ◽

Vol 71 ◽

pp. 194-198 ◽

Cited By ~ 4

Author(s):

Valentina Nekljudova ◽

Sibylle Loibl ◽

Gunter von Minckwitz ◽

Andreas Schneeweiss ◽

Stefan Glück ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Pathologic Complete Response ◽

Complete Response ◽

Early Stage Breast Cancer ◽

Term Outcome ◽

Abstract 5294: Biomarkers in residual disease after neoadjuvant chemotherapy of breast cancer predict long-term outcome

10.1158/1538-7445.am2015-5294 ◽

2015 ◽

Cited By ~ 1

Author(s):

Richard Buus ◽

Marie Klintman ◽

Amna Sheri ◽

Maggie Cheang ◽

Mitch Dowsett

Keyword(s):

Breast Cancer ◽

Residual Disease ◽

Term Outcome ◽